featured
Gabapentin 6% Topical Formulation for Chronic Kidney Disease–Associated Pruritus
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
International Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Randomized Controlled Study of 6% Gabapentin Topical Formulation for Chronic Kidney Disease-Associated Pruritus
Int. J. Dermatol 2020 May 27;[EPub Ahead of Print], TMO Aquino, KAC Luchangco, EV Sanchez, VM Verallo-RowellFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.